Applications Open for York Region’s 2026 Entrepreneurship and Innovation Fund

Applications are open for the 2026 Entrepreneurship and Innovation Fund, proudly supported by York Region and ventureLAB. With $10,000 available per stream, this is an opportunity to unlock the capital needed to take your high-impact ideas to the next level. 

This year, funding is split into two impactful paths:

🔹 Stream 1: For Non-Profits and Community Partners championing initiatives for under-represented communities. 

🔹 Stream 2: For Small Businesses and Entrepreneurs driving innovation in Agri-tech and Cleantech (including electric vehicles and precision agriculture).

Applications close on August 14.

Indo-Pacific AgeTech Canadian Technology Accelerator

The Canadian Trade Commissioner Service (TCS) is currently recruiting export-ready Canadian companies for the Indo-Pacific AgeTech Canadian Technology Accelerator (CTA).

The Indo-Pacific region's population aged 60 and above is expected to reach 1.3 billion by 2050. Markets such as Japan, Taiwan, Hong Kong, and Singapore are among the world's most advanced "silver economies," creating significant demand for innovation in eldercare, digital health, healthy ageing, and age-friendly technologies. 

This program is designed for growth-stage companies developing innovative solutions that address the needs of ageing populations, including:

• AgeTech and Healthy Ageing Solutions

• Digital Health Technologies

• AI-enabled Healthcare Applications

• Remote Monitoring and Care Technologies

• Assistive Technologies

• Healthcare Workforce Solutions

• Program Benefits

Participants will receive customized market development support across Japan, Taiwan, Singapore, and Hong Kong, including:

• In-depth market briefings on doing business in key Indo-Pacific markets

• Tailored mentorship and market-entry guidance

• Introductions to potential buyers, investors, and strategic partners

• Curated in-market programs across the four Indo-Pacific markets:

o   Tokyo: November 26 – 30, 2026 (TBC)

o   Taipei: December 3 – 6, 2026 coincides with Healthcare+ Expo, Taiwan

o   Singapore: December 8 – 11, 2026

o   Hong Kong: December 15 – 20, 2026 coincides with Gerontech and Innovation Expo cum Summit 2026

• How to Apply

To apply: please fill out the application form
Submission deadline: August 26, 2026

Please note that applicants must indicate interest in at least two (2) and up to four (4) of the listed markets when applying. Following the selection process, companies may be accepted into one or more markets based on their business objectives, market readiness, and program fit.

Applications Open for Mobility Unlimited Hub

In collaboration with MaRS, the Toyota Mobility Foundation is launching an open call for start-ups to join the third cohort of the Mobility Unlimited Hub in Toronto. Ten applicants will be selected to participate in the hub, which has become a global destination for active mobility technologies.

Who should apply?

 This program is designed to support active mobility technology companies that are creating a more sustainable and self-reliant experience for people living with disabilities. The Mobility Unlimited Hub is expanding the definition of active mobility to encompass brain health, paving the way for holistic innovations that support both physical vitality and cognitive well-being. 

What do you get?

• Up to $100,000 to support venture growth and commercialization efforts.

• Access to a coworking space in the MaRS Centre to collaborate, network and advance innovations.

• The opportunity to engage with Toyota Production System Support Center (TSSC) for expert guidance on scaling manufacturing operations.

• Brand enhancement and visibility through the Mobility Unlimited Hub brand and the MaRS PR Accelerator.

• A curriculum customized to a venture’s sector, stage and needs, focusing on building business, communication and leadership skills.

• Curated international market visits that provide direct access to foreign regulatory structures, global assistive-tech networks and trade showcases.

• Market intelligence services and much more.

Applications close on Friday, August 28, 2026 at 11:59 p.m. EST.

Applications open for Kids Brain Health (KBH+) Conference 2026: Pitch Competition

Do you have an innovation that could improve outcomes for kids with neurodisabilities?

Kids Brain Health (KBH+) is accepting submissions for the KBH+ Pitch Competition — a national showcase of the most promising solutions for children and youth (ages 0–25) living with neurodisabilities, and their families.

$50,000 in prizes. Three winners. One stage.

KBH+ is looking for solutions that are:
✅ Evidence-informed
✅ Implementation-ready
✅ Built to scale — improving equity, access, and impact for the families who need it most

Innovation can take many forms: technology, services, care models, community programs, or bold hybrid approaches.

Finalists will pitch live at the KBH+ Conference in Calgary on October 20, 2026, with select innovations considered for follow-on support through the Kids Brain Health Innovation Fund.

Apply by August 7.

Biotech and Healthtech Builders Social - Summer Edition

Come connect with fellow founders, operators, and aspiring entrepreneurs who are building - or exploring the idea of building - biotech and healthtech companies in Toronto at the new BioLabs at the University of Toronto.

​This is a casual networking event - no panels, pitches, or formal agenda.

​Just an opportunity to meet others in Toronto’s growing life sciences ecosystem, share ideas, and build new connections.

Life Sciences Central (powered by MaRS, OBIO® and TIAP) is sponsoring this event.

AI in Healthcare Research Internships

The University of Toronto’s Master of Science in Applied Computing Program (MScAC) is inviting industry partners and hospitals to participate in a unique opportunity to host computer science graduate students for 8-month applied research internships. 

MScAC students are trained in AI in healthcare and life sciences, and possess strong technical skills in machine learning, data science, computational biology/informatics, and software engineering, and are seeking real-world challenges in healthcare. Utilize MScAC expertise to solve complex technological challenges, pilot innovative ideas through rapid prototyping and proof of concept development, and build, test, and evaluate models using state-of-the-art tools, frameworks, and methods. The MScAC program has a partnership with Mitacs that can be leveraged to help subsidize internships for eligible partners. 

 Timeline:

Internships take place from May 2026 – December 2026. Project submission opens October 14th, 2025.

 Application Process:

If you are interested in participating and/or learning more, please email Daniele Chirico or the team.

Ontario Life Sciences Mission to Medical Fair Asia 2026 with outreach to Jakarta

The Government of Ontario is organizing a Life Sciences Export Business Mission to Singapore in conjunction with the Medical Fair Asia 2026 trade show, with an optional business outreach program in Indonesia.

For Ontario life sciences companies, attending Medical Fair Asia offers a strategic gateway into one of the fastest-growing healthcare markets globally. The event provides direct access to key buyers, distributors, and decision-makers from across Southeast Asia and beyond, enabling companies to expand export opportunities, establish regional partnerships, and better understand evolving regulatory and market needs.

To maximize the benefits of the trip, there is an optional reach-out program to Jakarta, Indonesia (Sep 14-15) to explore business potential in the country.

The planned program includes:
• 1:1 export advice and consultation
• Turnkey exhibit space within the Ontario pavilion
• Curated B2B matchmaking program in Singapore
• Company listing as an exhibitor on the event website
• Company listing on the SourceFromOntario website
• Marketing support, including a company directory
• In-market follow-up and support through Ontario's Trade & Investment Office in Singapore

ALL IN 2026

This September, Montreal will host ALL IN, a leading Canadian AI conference bringing together thousands of innovators, investors, researchers, and business leaders to explore the latest advances in artificial intelligence. For digital health professionals and companies, it is a valuable opportunity to discover emerging health-tech applications, gain insights from AI experts, and connect with partners shaping the future of healthcare. 

Note: If your company is Ontario-based and plans to attend, please consider reaching out to Aude-Alexia Véronneau from the Ontario Regional Office of Canada’s Trade Commissioner Service.

BioSTL 10th Annual Global Health Innovation Summit

Are you developing solutions that improve healthcare access and outcomes in rural communities?

The Consulate General of Canada in Chicago is partnering with BioSTL on the Global Health Innovation Summit (October 6–8, 2026, St. Louis). Connect directly with healthcare buyers representing more than $550B in purchasing power. Selected companies will have the opportunity to:

• Pitch to 200+ healthcare decision-makers

• Participate in curated 1:1 meetings with health systems, payers, and providers

• Access a dedicated Rural Health Day focused on solutions for underserved communities

• Learn from experts on U.S. market entry and healthcare commercialization strategies

If your innovation addresses rural health access, virtual care, aging at home, care coordination, AI in healthcare, or underserved populations, this is an excellent opportunity to build partnerships and grow in the U.S. market.

C2MP – Canada Chicago Mentoring Program

The Trade Commissioner Service (TCS) is partnering with MATTER, the leading life sciences and healthcare incubator in Chicago, to deliver the Canada-Chicago Mentoring Program (C2MP). The program will provide strategic guidance through team-based mentoring to five Canadian start-ups in the C2MP cohort. Accepted applicants will benefit from mentoring and guidance to sharpen their go-to-market strategy.

 Selected businesses will participate in an 8-month mentoring program that includes:

• a virtual day of acceleration 

• monthly meetings with your dedicated mentoring team

• educational workshops 

• an in-person pitch presentation at the end of the program 

This program is hybrid, with at least one visit to Chicago as well as virtual meetings from February to September 2026.  

Application deadline: October 24, 2025.

Build your best team yet: Become an I.D.E.A.L. Bioscience Employer in 2026

In today’s job market, people want more than pay. They want flexible work arrangements, a culture of belonging, strong leadership and opportunities for growth and learning. These are some of the everyday practices recognized by BioTalent Canada’s I.D.E.A.L. Bioscience Employer Recognition Program.This program lets you confidently and credibly brand your workplace as more than just a job. It shows employees you provide careers where they want to grow and belong.

The deadline to apply is November 28, 2025.

Apply to the Merck Digital Sciences Studio

Applications are now open for our 2026 cohort!

The Merck Digital Sciences Studio (MDSS) is a nine-month accelerator that invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development.

Selected startups gain direct access to Merck experts, personalized mentoring from Centech advisors, and a SAFE investment from the Merck Global Health Innovation Fund (GHI), in collaboration with regional partners The Venture Collective (United States) and CQDM (Canada). Through this collaborative approach, MDSS connects innovators, researchers, and industry leaders to accelerate breakthroughs in health technology.

Apply before November 28.

Industry-Based Internships in the Regenerative Medicine Sector

The SCN-Mitacs industry-based internship partnership aims to pair the brightest graduate students and postdoctoral fellows with RM-focused biotech companies that are moving innovative therapies and technologies into the marketplace. This internship partnership is offered through the Mitacs Accelerate program and will match candidates with Canadian companies to complete an eight-month internship. Successful candidates will gain exposure to and work experience in industry and develop fundamental technical and business skills by undertaking a stem cell and regenerative medicine-related project.

Fill this expression of interest by December 5.

StartUps in the 6ix 2025

StartUps in the 6ix is back for its 3rd rendition! Come out and join the digital health emerging leader and startup community for an exciting night of learning and connecting. We’ll have a fireside chat featuring Tomi Poutanen, CEO, Signal 1, moderated by Joshua Liu, CEO and Co-Founder of SeamlessMD, followed by a startup expo to feature digital health startups in the Ontario ecosystem!

RESI 2026

RESI Europe 2026 - March 23, 2026

Virtual Partnering - March 24 & 25, 30 & 31, 2026

RESI San Diego - June 22

Virtual Partnering - June 23 & 24, 29 & 30, 2026

OBIO® members can access exclusive discount codes by logging into the member portal.

RESI Boston - September 22-23

Virtual Partnering - September 25, 28-29, 2026

AI-driven Medicines (AIM)

The AI-driven Medicines (AIM) program aims to drive transformative research that leverages computational or digital-based methods and tools to address critical, real-world challenges in the discovery and development of accessible and affordable medicines. This initiative focuses on supporting the development of innovative methodologies and tools to accelerate the drug discovery and development pipeline, bridging the gap between advanced computational theory and practical therapeutic applications.

Application deadline is December 31, 2026.

IEC 60601-1 compliance: Integrating Risk Management (ISO 14971) into Medical Electrical Equipment Design

Gain practical, hands-on insight into IEC 60601-1, the globally recognized standard for the safety and essential performance of Medical Electrical Equipment (MEE) and learn how it supports international market access.

This virtual, instructor-led course provides a clear, structured introduction to the IEC 60601 series and shows how to integrate ISO 14971 Risk Management into product design, testing, and compliance activities.

Mitacs Launches New Defence and Security Funding Call

Mitacs launched a call for applications through our Accelerate program in the Defence and Security sector. This new competitive funding opportunity will support industrial innovation partnerships that advance Canadian sovereign capabilities in areas identified in Canada’s Defence Industrial Strategy (DIS). Delivered in collaboration with Canada’s Department of National Defence (DND), the call channels Canada’s top graduate and postdoctoral research talent into applied, mission-relevant projects that strengthen the country’s defence industrial base.

Application deadline is August 17, 2026.

Mitacs Accelerate Global Excellence Award

The Mitacs Accelerate Global Excellence Award aims to draw outstanding international researcher talent and Canadians currently studying abroad to industrial research projects in partnership with leading Canadian researchers - enabled by a competitive funding package of $170,000 over two years.

The application deadline has been extended until September 11, 2026.

Applications Open for ECBG Cohort 4

Applications are open for the 4th cohort of the Executive Corporate Board Governance (ECBG) program, an initiative led by Women in Bio Greater Montreal in collaboration with the Rotman School of Management.

Since 2022, ECBG has empowered over 75 life sciences leaders to strengthen their board readiness while advancing diversity, equity, and inclusion in governance.

Program highlights:

• 📅 Training: January–February 2027 (online)

• 📝 Recruitment: May–October 2026

• 🎓 Delivered with: Rotman School of Management

Whether you are an aspiring board member or an organization committed to strengthening governance, this is an opportunity to take action.

IPON Explained 2026

IPON Explained is designed to help innovators and ecosystem partners better understand the importance of intellectual property (IP) and how IPON can help Ontario innovators protect and grow what’s made-in-Ontario.

ASCENT26 Applications Now Open

ASCENT is Capital BioVentures' six-month cohort program built for pre-seed and seed stage Canadian therapeutics companies to get investor-ready.

During the program, companies will work through corporate development, product development, and financing strategy, with expert-led seminars, open office hours, 1:1 coaching from experienced biotech executives, pitch practice sessions, investor introductions, and so much more. Companies will pitch to investors at the CBV Pitch Competition, with a cash prize available.

All companies will be presented with a final diligence report summarizing opportunities to accelerate growth. Based on final diligence assessments, select companies will be invited to the prestigious RIDGE and SUMMIT accelerator, becoming part of the CBV portfolio.

Application deadline: August 3, 2026

Program launch: September 15, 2026

For more info, write to the Capital BioVentures team.

BioHubNet EXPERIENCE Program: Build experience in the setting that moves you forward

Gain practical experience through industry internships and collaborative research placements that prepare you for careers in Canada's biomanufacturing and life sciences sectors.

Applications for Round II of Ontario's Life Sciences Scale-Up Fund Now Open

The Life Sciences Scale-Up Fund is designed to help small and medium-sized Ontario health technology companies scale their operations, commercialize products and services, and increase domestic manufacturing capacity. Together with the Health Innovation Fund, the LSSUF will advance the Phase 2 goals of Ontario’s Life Sciences Strategy and strengthen Ontario’s standing as a global leader in health innovation.

To assess your company’s eligibility for the Life Sciences Scale-Up Fund, please access the Government of Ontario’s LSSUF page to review the requirements.

To read the Government of Ontario’s full news release, click here.

Applications are open from June 22 to August 4.

Join ElevateHER

ElevateHer is a workplace mentorship and sponsorship initiative of Times Change Women’s Employment Service that partners with employers across the Greater Toronto Area to strengthen women’s career advancement through systemic workplace change.

Designed to address barriers affecting the career progression of equity-deserving women, we work with employers to implement internal mentorship and sponsorship models through practical training, ready-to-use resources, implementation support, and ongoing coaching. Whether launching a new initiative or strengthening an existing one, employers are supported to test and refine approaches that foster more inclusive workplaces and leadership pathways.

ElevateHer is funded by Women and Gender Equality Canada (WAGE) as part of a systemic change initiative to advance gender equity in Canadian workplaces.

Interested in getting involved? Write to the ElevateHER team.

Octane LaunchPad Accelerator for Canadian Life Sciences Companies

Octane’s LaunchPad Accelerator is a virtual program designed to help high-potential Canadian companies accelerate market entry into Southern California’s dynamic life sciences ecosystem. Participants will gain access to:

• Tailored 1:1 mentorship from industry experts

• Specialized workshops and business programming

• Capital raising and fundraising advisory support

• Exclusive networking and partnership opportunities

• Access to Octane’s signature industry events

In addition, companies that apply to the LaunchPad may be eligible for invitations to attend and/or pitch at selected Octane events, including:

• Octane Medical Innovation Forum – October 27–28, 2026

• Octane Aesthetics Tech Forum – January 7–8, 2027

We are particularly interested in reaching companies developing solutions and technologies in:

• Medical technologies

• Medical devices

• Aesthetics and related health innovation sectors

Applications will be reviewed on a rolling basis and submitted to Octane for consideration until August 3, 2026.

Global Medtech Showcase

Applications are now open for One Six 8 Ventures’ virtual Global Medtech Showcase on September 29th at 11 AM EST! This is your opportunity to showcase your technologies to global investors, partners, and key stakeholders in MedTech.

The last event drew:
- 200+ registrants
- 120+ company applications from 14 countries

Company Requirements:
- Focus: AI Medtech, Surgical & Robotics, Remote Patient Monitoring (RPM), or Digital Health
- Stage: Preferred Seed to Series A
- Scope: Medical device focused innovations (Global companies welcome)

Application deadline is August 20.

OBIO® is proud to be among the sponsor partners of this event.

Fill this short survey for BioTalent Canada

As Canada's bio-economy continues to grow, BioTalent wants to ensure they are supporting employers like you in the ways that matter most.

This short survey will help them better understand the challenges you are facing, your perspectives on talent and workforce needs and where BioTalent Canada can be of greatest value to your organization.

The survey takes approximately 5-7 minutes.

Call for Ideas: Next-generation immunotherapies

CQDM is pleased to launch a call for ideas for the upcoming CQDM Connect-Pharma: Pitch Day, focused on next-generation immunotherapies. Selected applicants will present their innovations to experts from CQDM’s global pharmaceutical members on September 16, 2026.

The objective is to bring ground-breaking, innovative Canadian research to CQDM’s pharmaceutical members and facilitate interactions between their pharma members and the Canadian ecosystem.

Submission Deadline: August 17, 2026

Funding Opportunity to Support Innovation in Quebec’s Biopharma Sector

Through the SynergiQc program , the CQDM aims to stimulate industrial biopharmaceutical research carried out in collaboration with public research centres in order to generate positive economic benefits for Quebec.

SynergiQc allows a vast network of diverse companies working in the life sciences (pharmaceutical companies, biotechnology companies, contract research organizations (CROs), etc.) to participate, in groups or individually, in carrying out R&D projects that meet their specific needs.

Next Submission Deadline: August 18, 2026

Silicon Valley Agentic and Enterprise AI Canadian Technology Accelerator 2026-27

Artificial intelligence (AI) is reshaping every industry and Silicon Valley remains the epicenter of innovation, investment, and adoption. This program provides Canadian AI companies with a direct pathway to scale into the United States (U.S.) market.

Led by the Consulate General of Canada in Palo Alto, this Canadian Technology Accelerator (CTA) is designed to help Canadian AI companies fast-track their U.S. growth through direct access to enterprise buyers, strategic investors, and world-class innovation partners.

The CTA is anchored around The AI Conference (September 29 to October 1 in San Francisco), a premier gathering shaping the future of artificial intelligence. You'll be in the room with the industry's most influential builders, buyers, and backers.

Spots are limited. Apply before July 15.

Ontario Life Sciences Export Business Mission to Mexico City

The Ontario Government in collaboration with the Ontario Trade and Investment Office and the Canadian Embassy in Mexico City, invite you to join the Ontario Life Sciences Export Business Mission to Mexico. This Mission will be of interest to Ontario companies in the digital health and medical technology sectors. The objective of the mission is to assist companies learn about what is required to do business in Mexico, thereby enabling them to  enter the market and develop sales.

If you have any questions, please write to Patricia Cosgrove.

Apply by June 26.

Ontario AI & Big Data Export Business Mission to Big Data & AI Paris 2026

Big Data & AI Paris is one of Europe’s leading events focused on artificial intelligence, data technologies, cloud computing, and enterprise digital transformation. Held annually in Paris, the event attracts more than 20,000 participants and over 350 exhibitors, including senior decision-makers from sectors such as finance, manufacturing, telecommunications, transportation, energy, retail, and government. The Ontario mission will include turn key exhibitor space within the Ontario pavilion, targeted B2B matchmaking, group briefings, and strategic networking activities designed to connect Ontario firms with European buyers, integrators, and innovation partners seeking advanced AI and data solutions.

The mission will be delivered in close collaboration with Ontario’s Trade and Investment Offices in Europe, the Trade Commissioner Service, and relevant industry associations.

Booths will be assigned on a first-come, first-served basis. Companies that complete payment first will have priority in selecting their booth location. Applications will be reviewed and approved as they are received, so it’s important that companies complete the registration by paying the fee promptly to secure their spot.

Cost: CAD $4,980.00.

For any questions, please reach out to Arman Giloyan or Mauricio Ospina.

Oncology Accelerator in France

The Trade Commissioner Service (TCS) Service is pleased to open applications for the Oncology Accelerator in France, taking place from September 21–24, 2026.

This mission is designed for innovative Canadian SMEs and scale-ups in oncology looking to accelerate their expansion into the French and European markets through meetings with leading pharmaceutical companies, research institutes, and key players in the French ecosystem.

More information about the program is available on this One Pager.

There will also be an information webinar on June 8 to present the program and answer questions.

 Applications are open until June 21.

AI in Hospitals: From Hype to Implementation

This conference is highly relevant to Ontario’s digital health community, bringing together leaders from hospitals, health systems, and government to address the practical challenges of implementing AI in clinical environments. With speakers from organizations such as Humber River Health, North York General Hospital, Unity Health, and Hamilton Health Sciences, the event focuses on topics that are top of mind for Ontario healthcare organizations - including AI governance, clinician adoption, data readiness, privacy, and scaling successful innovations across the health system.

Note: “super early bird” and “early bird” registration discounts available until July 10 and August 21, respectively)

Good Documentation Practices (GDP): A Hands-On Introduction

This 1-day Good Documentation Practices (GDP) workshop equips participants with the practical documentation and data integrity skills required to work confidently in a GMP-regulated environment. Grounded in harmonized GDP principles, this full-day workshop bridges the gap between regulatory knowledge and day-to-day documentation practice. Through a combination of targeted instruction and hands-on activities, participants learn to write compliant SOPs, review and correct batch records, and execute documentation in real time.

Learning Objectives

• Identify the key principles of GDP and their application

• Apply ALCOA+ principles to paper-based records and identify common data integrity violations

• Recognise and classify documentation error codes and apply GMP-compliant corrections

• Distinguish between the document types used in GMP/GDP settings (SOPs, batch records, logbooks, CoAs, deviations, and more)

• Understand the principles for drafting GMP-compliant documents

• Gain confidence in the execution and review of manufacturing batch records through practical exercises

Who Should Attend

Ideal for anyone working in or transitioning into a GMP/GDP-regulated environment, including biomanufacturing operators, QA/QC staff, and production supervisors. No prior documentation training is required, though basic familiarity with GMP concepts is an asset. This course complements CASTL’s GMP Readiness Accelerator workshop and is designed to stand alone for open-enrolment participants.

September 24 I Montreal - Register here

October 8 I Charlottetown - Register here

Ontario Defence Business Mission to BIO Japan 2026 and Outreach Korea

October 7-9, 2026, and October 12, 2026

The Government of Ontario is leading a Life Science Business Mission to BIO Japan (October 7-9, 2026) in Yokohama, Japan, and Outreach Mission to Korea (October 12, 2026) in Seoul, South Korea.

BIO Japan 2026

• BIO Japan 2026 comprises 3 co‑located exhibitions (BioJapan, Regenerative Medicine, and healthTECH) with Exhibition, Seminars, and Partnering Programs. Ontario life science Mission to Bio Japan 2026 will take place at Pacifico Yokohama from October 7th to 9th, with the Ontario Pavilion. Bio Japan is the world's oldest biotechnology exposition and is the cornerstone of biotechnology industry in Japan providing platform for innovation and collaboration in biotechnology. Bio Japan 2025 had 500+ exhibitors and 30,000 visitors. Please find additional details of BIO Japan 2026 on the event webpage (https://jcd-expo.jp/en/).

• Exhibiting at Bio Japan (Yokohama, Japan) provides biopharmaceutical, life sciences, regenerative medicine, digital health, imaging, and medical technology companies in Ontario with opportunity to meet with potential customers and sales/distribution partners in Japan, and around the world. BIO Japan mission provides an opportunity to introduce Ontario life sciences (medical and assistive devices, digital health, AI, robotic, sensor and security, healthcare entertainment and management technologies) and bio sciences (drug discovery, drug development, drug manufacturing) companies to Japanese healthcare providers (hospital, clinics, long term care facilities, senior home etc.) and bio science companies (drug manufacturers, universities and clinical researches) as well as sales and distribution partners, and unlocking new export markets in Japan and increasing exports for Ontario companies. 

• Interested mission members are welcome to join extension Outreach Mission organized in Seoul, South Korea after the visit to Japan. South Korea presents a significant market potential. South Korea is proximity with Japan, sharing similar business culture. Outreach program in Seoul will include a market briefing session and curated B2B meetings at the Canadian Embassy follow-up meetings or group visit to a large Korean corporation.

• Ontario’s Trade and Investment Offices in Tokyo and Seoul will support programming and in‑market activities.

Who should participate? 

Ontario companies, which are interested in Japanese and/or /Korean life science markets, can showcase their products, services, and technologies at BIO Japan, which is ideal for Ontario Companies across the life‑science ecosystem, including biotech and pharmaceutical companies seeking partnerships and licensing deals, medical device manufacturers exploring digital health, diagnostics and regenerative medicine, chemical and materials companies working on biotech applications in materials and enzymes, research institutes aiming to commercialize discoveries, startups looking for visibility and investment, investors scouting emerging technologies, government and regulatory bodies supporting industry development, and service providers such as CROs and CDMOs who work with companies throughout the R&D and commercialization pipeline. These groups attend because BIO Japan is Asia’s most concentrated hubs for partnering, technology scouting, and cross‑border collaboration.

For further info, please reach out to Stephen Ip at MEDJCT.

BioFuture Conference

BioFuture participants reflect a broad spectrum of pioneering companies, investors, partners, visionaries, and key opinion leaders influencing the rapid changes in therapeutics and technology today.

OBIO® members can access exclusive discount codes for presenting companies and attendee registration by logging into the member portal.

Trade Mission to BIO-Europe 2026

The Ontario Government in partnership with the Ontario Trade and Investment Office in Munich Germany, the Canadian Consulate in Dusseldorf, Germany, invites you to join the Ontario Export Business Mission to BIO-Europe.

The objective of this mission is to assist Ontario life sciences/biotechnology companies identify and meet with potential partners, customers, and investors, individuals companies would not normally have the opportunity to meet. BIO-Europe is an international forum designed to promote business development between pharmaceutical, financial and biotechnology companies. The event is Europe's largest partnering conference serving the global biotech industry. It offers networking opportunities, workshop and panel participation, high-profile exhibitions and prearranged one-on-one meetings. The event draws more than 4,000 delegates from over 60 companies.

Invest Ontario will have a 400 square-foot pavilion co-located with Global Affairs Canada, British Columbia and Quebec. This will serve as a convenient meeting place for the Ontario companies.

Apply before July 3.

MEDICA/Compamed trade fair

MEDICA/Compamed trade fair is one of the world’s largest medical trade fairs and a leading platform for showcasing innovations in healthcare technologies, medical devices, and digital health solutions.

The Canadian Trade Commissioner Service (TCS) will support Canadian companies attending MEDICA/Compamed through the following activities: 

• Canada Pavilion: A central hub on the exhibit floor for Canadian participants to connect with European industry leaders. 

• Networking Reception: At the Canada Pavilion, celebrating Canada-Germany milestones. 

• B2B Matchmaking: together with German partners (associations, clusters) DDORF will offer a matchmaking activity. 

• Export Café: meet Trade Commissioner from Europe and learn about their markets 

To express your interest in joining the Canadian delegation, contact our Trade Commissioner in Germany, Silke Ditgen.

Registration deadline is September 15.